ENvue Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-18.2M | $-3.7M | $-3.7M | $-5.4M | $-14.3M | $-4.3M | $-5.8M | $-4.2M |
| Depreciation & Amortization | $897.0K | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $6.0K |
| Depreciation | — | — | — | — | — | — | $4.0K | $6.0K |
| Amortization | $855.0K | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $356.0K | $293.0K | $354.0K | $382.0K | $376.0K | $1.8M | $889.0K |
| Net Cash from Operating Activities | $-9.4M | $-2.5M | $-3.6M | $-7.0M | $-4.4M | $-3.4M | $-3.9M | $-3.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $60.0K | $3.0K | $1.0K | $3.0K | $3.0K | $2.0K | — | $8.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $88.0K | $-3.0K | $-1.0K | $-3.0K | $-3.0K | $-2.0K | — | $-8.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.8M | $1.0K | $4.2M | $2.1M | $4.6M | $9.5M | $4.3M | $94.0K |
| Net Change in Cash | $3.5M | $-2.5M | $570.0K | $-5.0M | $204.0K | $6.2M | $442.0K | $-3.5M |
| Free Cash Flow | $-9.4M | $-2.5M | $-3.6M | $-7.0M | $-4.4M | $-3.4M | — | $-3.6M |